CHP300

26
CHP300

description

CHP300. Content. Definition of Immunization Immunization Schedule Success of Immunization. Assessment of Success Factors Influencing Success. The Cold Chain. Definition of Immunization. skin. mucous membranes. Non specific. reflexes. sp. variation. race. genetic. anomalies. - PowerPoint PPT Presentation

Transcript of CHP300

Page 1: CHP300

CHP300

Page 2: CHP300

Content Definition of Immunization Immunization Schedule Success of Immunization

• Assessment of Success • Factors Influencing Success

The Cold Chain

Page 3: CHP300

Non specific

specific

skinmucous membranes

reflexes

genetic

sp. variation

race

anomalies

acquired

natural

passive ( transplacental )

active ( disease )

artificialactive

toxoidlive vacckilled vacc

passive homologous Abs

heterologous Abs

Resistance

Definition of Immunization

Artificially acquired specific resistance

Page 4: CHP300

Vaccine:

A suspension of attenuated live or killed

microorganisms or antigenic portion of

these agent presented to a potential host

to induce immunity and prevent disease.

Definitions

Page 5: CHP300

Toxoid:

A modified bacterial toxin that has

been made nontoxic but remains the

capacity to stimulate the formation of

antitoxin

Definitions

Page 6: CHP300

Antitoxin :

An antibody derived from the serum of

animals from stimulation with specific

antigen used to provide passive immunity

Definitions

Page 7: CHP300

Definitions

Immunoglobulin:

An antibody-containing solution derived from

human blood and used primary for

maintenance of immunity of immunodeficient

person or for passive immunization.

Page 8: CHP300

• Attenuated strain of M.bovis. • Site: intradermal. Safe in immunocompetent patient. 50 – 80%Protection against disseminated

tuberculosis and tuberculus meningitis 50% protection against pulmonary

tuberculosis in children and adults

BCG vaccine

Page 9: CHP300

IPV: trivalent inactivated poliovirus type

1,2 and 3

OPV : trivalent live attenuated poliovirus

type 1,2 and 3

Protection against Poliomyelitis

Poliov accine

Page 10: CHP300

• Vaccine administration• IPV = SC• OPV = PO

Page 11: CHP300

DPT = diphtheria and tetanus toxoids combined to

a whole-cell pertussis.

DTaP = diphtheria and tetanus toxoids combined

to a cellular pertussis vaccine

DT = for children <7yrs with contraindication to

pertussis Td = tetanus toxoid with1/3 -1/6 the dose of

diphtheria toxoid for individuals >7yrs• Site = IM

DTP

Page 12: CHP300

• Consist of a capsular polysaccharide

antigen conjugated to a carrier (doesn’t

protect against the disease)

• Protection against bacteremia, pneumonia,

and acute bacterial meningitis.

Haemophilus influenzae type B (Hib) vaccine

Page 13: CHP300

• Routine use of these vaccine has lead to

a 95% decline in invasive Hib disease in

infancy and young children.

• Vaccine administration :IM

Page 14: CHP300

• Indications:• Routine• All infant of HBsAg positive mother• All children and adolescents not immunized• High risk group: o Health workers.o Haemodialysis, bleeding disorders.o Travellers to endemic areas.

Hepatitis B vaccine

Page 15: CHP300

Introduction of pentavalent vaccine

• DPT• Hepatitis B• Hib

Page 16: CHP300

• Live attenuated viruses. measles and mumps

grown in chick embryo cell while rubella in

human diploid cells.

• Monovalent measles vaccine, rubella vaccine

and measles/rubella MR formulations are

available. Vaccine administration: SC

MMR

Page 17: CHP300

The varicella vaccine is  a 

live (attenuated) virus administered to

protect against  chickenpox 

Given subcutaneously (under the skin).

Two doses are always recommended

Varicella Vaccine 

Page 18: CHP300

Quadrivalent (Serogroups A, C, W-135 and

Y)

MCV4 is administered intramuscularly.

MCV4

Page 19: CHP300

Rota VV Live attenuated

Given orally in 2 doses

Page 20: CHP300

Immunization Schedule

KSA ( most resent)

Birth

2 mo

4 mo

6 mo

9 mo

12 mo

18 mo

24 mo Schoolentry

BCG

DTaP1

DTaP2

DTaP3

Measles1(mono)

M2MR1

DTaPB1

HepAV2

DTaPB2

HepBV1

HibV1

HibV2

HibV3

OPV4

HibVB

OPVB2

IPV1

IPV2

IPV/OPV3

OPVB1

M4MR3 Varicella2

HepBV2

HepBV3

HepBV4

HepAV1

PCV1

PCV2

PCV3

PCVB

/Td

Rota

Rota

MCV4

MCV4

Varicella1 M3MR2

vaccineinformation.org

Page 21: CHP300

- Coverage- Seroconversion

Success of Immunization

Assessment of Success

Page 22: CHP300

- Parents

- Staff

- Vaccine

Factors Influencing Success

KAPAvailability

CommitmentSkill

EfficacyStability

Success of Immunization

( H.E. )( √ )

( Selection )( Training )

( Choice )( Cold Chain )

Page 23: CHP300

It is a temperature-controlled supply chain. It is

a system of storage , transport and distribution

of vaccines at a low temperature from

manufacturer to the actual vaccination site.

range

Cold chain

Page 24: CHP300

mjkjbhkjbbk

ManufacturerGround

TransportAirport Airplane

Airport

Terminal

Intermediate

Stops&Transfers

Distributor’sWarehouse

ConsumerOutlet

Consumer

Pharma / Biotech Cold Chain

Destination

Page 25: CHP300
Page 26: CHP300

THANK YOU